Let's Find Out Who Will Use It Before We Waste A Billion Dollars

The tragic loss of the space shuttle Challenger has not only disrupted the U.S. space program, it has also disrupted the process for planning the program. The current debate over the manned space station and the commercially developed space facility, an unmanned platform that would be launched and serviced by the shuttle in the early 1990s, is symptomatic of the present disarray. NASA’s problem is that it continues to employ a supply-side policy of investing in space. This is true for b

Written byJohn Pike
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

NASA’s problem is that it continues to employ a supply-side policy of investing in space. This is true for both the large manned space station and the industrial space facility (ISF). The development of hardware for the space station, for example, is far ahead of the development of experiments for the station. The science community that is dependent on NASA funding is properly concerned that, as with the shuttle, the station budget will make demands on NASA’s budget at the expense of planetary and space science.

The industrial space facility appears to be another example of such supply-side space policy. NASA wants to go ahead, even though no one has a clear sense of user requirements and priorities. The ISF is touted both as a near-term low-cost replacement for the space station and as a bridge to the development of the station. While one of these characterizations may be right, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery